Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Disability in Fibromyalgia Associates with Symptom Severity and Occupation Characteristics.

Fitzcharles MA, Ste-Marie PA, Rampakakis E, Sampalis JS, Shir Y.

J Rheumatol. 2016 May;43(5):931-6. doi: 10.3899/jrheum.151041. Epub 2016 Mar 15.

PMID:
26980580
2.

Medical use of cannabis products: Lessons to be learned from Israel and Canada.

Ablin J, Ste-Marie PA, Schäfer M, Häuser W, Fitzcharles MA.

Schmerz. 2016 Feb;30(1):3-13. doi: 10.1007/s00482-015-0083-4.

PMID:
26767992
3.

Efficacy, Tolerability, and Safety of Cannabinoid Treatments in the Rheumatic Diseases: A Systematic Review of Randomized Controlled Trials.

Fitzcharles MA, Ste-Marie PA, Häuser W, Clauw DJ, Jamal S, Karsh J, Landry T, Leclercq S, Mcdougall JJ, Shir Y, Shojania K, Walsh Z.

Arthritis Care Res (Hoboken). 2016 May;68(5):681-8. doi: 10.1002/acr.22727.

PMID:
26548380
4.

Real-life assessment of the validity of patient global impression of change in fibromyalgia.

Rampakakis E, Ste-Marie PA, Sampalis JS, Karellis A, Shir Y, Fitzcharles MA.

RMD Open. 2015 Sep 14;1(1):e000146. doi: 10.1136/rmdopen-2015-000146. eCollection 2015. Erratum in: RMD Open. 2015;1(1):e000146corr1.

5.

Re: Harth M, Neilson WR. Fibromyalgia and disability adjudication: no simple solutions to a complex problem. Pain Res Manag 2014;19(6):293-299.

Fitzcharles MA, Ste-Marie PA, Mailis A, Shir Y.

Pain Res Manag. 2014 Nov-Dec;19(6):300-1. No abstract available.

6.

Adjudication of fibromyalgia syndrome: challenges in the medicolegal arena.

Fitzcharles MA, Ste-Marie PA, Mailis A, Shir Y.

Pain Res Manag. 2014 Nov-Dec;19(6):287-92.

7.

Management of fibromyalgia in older adults.

Fitzcharles MA, Ste-Marie PA, Shir Y, Lussier D.

Drugs Aging. 2014 Oct;31(10):711-9. doi: 10.1007/s40266-014-0210-4. Review.

PMID:
25227451
8.

Rheumatologists lack confidence in their knowledge of cannabinoids pertaining to the management of rheumatic complaints.

Fitzcharles MA, Ste-Marie PA, Clauw DJ, Jamal S, Karsh J, LeClercq S, McDougall JJ, Shir Y, Shojania K, Walsh Z.

BMC Musculoskelet Disord. 2014 Jul 30;15:258. doi: 10.1186/1471-2474-15-258.

9.

The association of socioeconomic status and symptom severity in persons with fibromyalgia.

Fitzcharles MA, Rampakakis E, Ste-Marie PA, Sampalis JS, Shir Y.

J Rheumatol. 2014 Jul;41(7):1398-404. doi: 10.3899/jrheum.131515. Epub 2014 Jun 15.

PMID:
24931954
10.

The dilemma of medical marijuana use by rheumatology patients.

Fitzcharles MA, Clauw DJ, Ste-Marie PA, Shir Y.

Arthritis Care Res (Hoboken). 2014 Jun;66(6):797-801. doi: 10.1002/acr.22267. Review. No abstract available.

11.

Dr. Fitzcharles, et al reply.

Fitzcharles MA, Ste-Marie PA, Shir Y.

J Rheumatol. 2013 Sep;40(9):1622. No abstract available.

PMID:
24137772
12.

Concerns with fibromyalgia guidelines.

Fitzcharles MA, Ste-Marie PA.

CMAJ. 2013 Sep 17;185(13):1160-1. doi: 10.1503/cmaj.113-2133. No abstract available.

13.

Canadian Pain Society and Canadian Rheumatology Association recommendations for rational care of persons with fibromyalgia: a summary report.

Fitzcharles MA, Ste-Marie PA, Goldenberg DL, Pereira JX, Abbey S, Choinière M, Ko G, Moulin DE, Panopalis P, Proulx J, Shir Y.

J Rheumatol. 2013 Aug;40(8):1388-93. doi: 10.3899/jrheum.130127. Epub 2013 Jul 1.

PMID:
23818709
14.

2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary.

Fitzcharles MA, Ste-Marie PA, Goldenberg DL, Pereira JX, Abbey S, Choinière M, Ko G, Moulin DE, Panopalis P, Proulx J, Shir Y; National Fibromyalgia Guideline Advisory Panel.

Pain Res Manag. 2013 May-Jun;18(3):119-26.

15.

Fibromyalgia: evolving concepts over the past 2 decades.

Fitzcharles MA, Ste-Marie PA, Pereira JX; Canadian Fibromyalgia Guidelines Committee.

CMAJ. 2013 Sep 17;185(13):E645-51. doi: 10.1503/cmaj.121414. Epub 2013 May 6. Review. No abstract available.

16.

Opioid use in fibromyalgia is associated with negative health related measures in a prospective cohort study.

Fitzcharles MA, Faregh N, Ste-Marie PA, Shir Y.

Pain Res Treat. 2013;2013:898493. doi: 10.1155/2013/898493. Epub 2013 Mar 18.

17.

A medicolegal analysis of worker appeals for fibromyalgia as a compensable condition following workplace soft-tissue injury.

Fitzcharles MA, Ste-Marie PA, Shir Y.

J Rheumatol. 2013 Mar;40(3):323-8. doi: 10.3899/jrheum.121062. Epub 2013 Jan 15.

PMID:
23322465
18.

The 2010 American college of rheumatology fibromyalgia survey diagnostic criteria and symptom severity scale is a valid and reliable tool in a French speaking fibromyalgia cohort.

Fitzcharles MA, Ste-Marie PA, Panopalis P, Ménard H, Shir Y, Wolfe F.

BMC Musculoskelet Disord. 2012 Sep 20;13:179. doi: 10.1186/1471-2474-13-179.

19.

Association of herbal cannabis use with negative psychosocial parameters in patients with fibromyalgia.

Ste-Marie PA, Fitzcharles MA, Gamsa A, Ware MA, Shir Y.

Arthritis Care Res (Hoboken). 2012 Aug;64(8):1202-8. doi: 10.1002/acr.21732.

20.

Clinical implications for cannabinoid use in the rheumatic diseases: potential for help or harm?

Fitzcharles MA, McDougall J, Ste-Marie PA, Padjen I.

Arthritis Rheum. 2012 Aug;64(8):2417-25. doi: 10.1002/art.34522. Review. No abstract available.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk